In previous studies, novel putative viral pathogens designated that asinine herpesvirus 4 (AsHV4) and asinine herpesvirus 5 (AsHV5) were associated with fatal interstitial pneumonia in donkeys (Equus asinus). Nucleotide sequence analysis of a portion of the DNA polymerase gene identified these putative pathogens as herpesviruses and possibly as members of the Gammaherpesvirinae subfamily. Although similar to equine herpesvirus 2 (EHV2) and equine herpesvirus 5 (EHV5), sequence diversity was observed among the detected viruses. In this study, novel sequence is reported for a DNA-packaging protein gene of EHV5 plus AsHV4, AsHV5, and a newly described putative pathogen herein designated asinine herpesvirus 6 (AsHV6). Phylogenetic analysis of these sequences suggested that the equine gammaherpesviruses may form a separate clade within the Gammaherpesvirinae subfamily. Based on the sequence of EHV2 and the novel sequences reported in this study, a PCR assay was developed to detect equine gammaherpesviruses. Products of the predicted size were produced after amplification of DNA from EHV2, EHV5, AsHV4, AsHV5, and AsHV6. This nonnested assay was shown to consistently amplify approximately 10 genomic copies of EHV2. Amplification products were not produced from DNA template of other alpha-and gammaherpesviruses. Because the role of gammaherpesviruses has not been well defined in equine disease, it is envisioned that a single, sensitive PCR assay to detect these potential pathogens will facilitate further assessment of their role in disease.
The Herpesviridae family of viruses contains a broad range of pathogens that have been grouped into the subfamilies Alpha-, Beta-, and Gammaherpesvirinae based on both biological and genomic characterization. Diseases caused by herpesviruses range from mild or inapparent to clinically severe and potentially fatal. Herpesviruses have been identified in nearly every animal species examined, and members of all subfamilies can survive and persist in a population of animals because of the propensity of these pathogens to persist, often through latency, in individual hosts. 35 In latently infected hosts, virus may periodically reactivate and shed, and this may be an important mechanism that allows herpesviruses to perpetuate, even in small isolated host groups.
A number of alphaherpesviruses have been isolated or detected from a range of equine species. The most important of these pathogens are equine herpesvirus 1 and equine herpesvirus 4, which cause significant reproductive losses and respiratory disease in horses worldwide. 26, 28 Equine herpesvirus 3 (EHV3), which is the etiologic agent of equine coital exanthema, is an alphaherpesvirus that causes distinctive but self-limiting genital lesions in horses. 26 Asinine herpesvirus 1 (AsHV1) was isolated from a donkey foal with lesions similar to those caused by EHV3, but this virus was shown by Southern blot hybridization to be a related, although genetically distinct, alphaherpesvirus. 5 Asi-From the Veterinary Medical Diagnostic Laboratory and the Department of Veterinary Pathobiology, University of Missouri, College of Veterinary Medicine, Columbia, MO 65211. 1 Corresponding author. nine herpesvirus 3 (AsHV3) was isolated from healthy donkeys after steroid treatment and was shown to have the greatest genetic similarity to equine herpesvirus 1, suggesting that like AsHV1, AsHV3 was a member of the Alphaherpesvirinae subfamily.
Equine herpesvirus 2 (EHV2) and equine herpesvirus 5 (EHV5), members of the Gammaherpesvirinae subfamily, 40 are also widespread in the equine population, 26 but the role of these viruses in equine disease has not been well established. Equine herpesvirus 2 has been linked to respiratory disease, conjunctivitis, and general malaise in horses. 4, 8, 19, 20, 30, 38, 39, 40 However, several studies have also found EHV2 in the respiratory tract and peripheral blood leukocytes of clinically normal horses, with isolation or PCR detection rates ranging from 31% to 89%. 4, 19, 32, 34, 38 After experimental inoculation of EHV2 into both juvenile and adult horses, chronic pharyngitis was observed in the young horses, whereas the adult horses remained unaffected. 3 As with other gammaherpesviruses, latency in lymphocytes has been demonstrated for EHV2. 9 A second gammaherpesvirus of horses, EHV5, has been isolated but is less well characterized when compared with EHV2 and has not yet been associated with disease, 1, 6, 40 although the results of experimental inoculations of EHV5 have not been reported. Related but distinct gammaherpesviruses have recently been identified by consensus primer PCR in zebras and a Somali wild ass. 11 No disease symptoms were reported in the animals from which these viruses were detected. Gammaherpesviruses have also been detected in donkeys. 5, 21 The first gammaherpesvirus of donkeys to be detected, designated asinine herpesvirus 2 (AsHV2), was isolated from the blood of a healthy donkey. 5 In contrast, asinine herpesviruses 4 (AsHV4) and asinine herpesvirus 5 (AsHV5), both of which are most similar genomically to gammaherpesviruses of equids, were detected in lung tissue of donkeys in which acute and typically fatal respiratory disease was a prominent feature of the clinical history. 21 Histopathology from these animals consistently included interstitial pneumonia with marked syncytial cell formation. Virus isolation was not successful on samples collected from affected donkeys; thus, experimental inoculation studies have not yet been possible.
In this report, novel sequences were identified for a DNA-packaging protein (terminase) gene of a number of related yet genetically distinct gammaherpesviruses of equids. Phylogenetic analysis suggested that these putative viral pathogens form a separate clade within the Gammaherpesvirinae subfamily. Identification of conserved regions within the newly described sequences allowed development of a nonnested PCR assay that allows rapid, sensitive detection of these closely related equine gammaherpesviruses.
Template for amplification of EHV5 was prepared from lung tissue collected at necropsy that was previously confirmed to contain EHV5 by consensus primer PCR 42 and nucleotide sequencing of a portion of the DNA polymerase gene. Comparison of the nucleotide sequence generated to that of EHV5 (Gen-Bank accession no. AF141886) demonstrated 100% identity over the region examined. The template for amplification of AsHV4.1, AsHV4.2, and AsHV5 was prepared from either fresh lung tissue or formalinfixed, paraffin-embedded lung samples as described previously. 21 Template for amplification of asinine herpesvirus (AsHV6) was prepared from lung tissue collected at necropsy from an adult donkey that died after a clinical history of severe respiratory disease. Interstitial pneumonia with syncytial cell formation was a prominent finding of the postmortem examination of this animal.
Tissue samples collected at necropsy were homogenized in phosphate-buffered saline (pH 7.4; 2-4 g of lung tissue per 5 ml). One milliliter of this homogenate was centrifuged at 12,000 ϫ g for 1 minute, and the cell pellet was used for DNA extraction. Formalinfixed, paraffin-embedded tissue sections of lung (2 sections per paraffin block, 20 m thick for each section) were deparaffinized by 2 extractions with xylene, followed by centrifugation. Tissue pellets were then washed twice with 100% ethanol and dried for 10 minutes at room temperature. For DNA extraction from both fresh tissue and paraffin-embedded tissue sections, samples were digested with proteinase K a in Buffer ATL a for a minimum of 12 hours at 55 C. The DNA extractions were performed using the QIAamp DNA mini kit a according to the manufacturer's instructions. For each of the DNA extraction steps, strict protocols were followed to avoid cross-contamination of samples. A negative control DNA extraction was performed with each set of tissues using equine lung, kidney, and spleen samples shown to be negative for herpesvirus DNA by consensus primer PCR of the DNA polymerase gene. 42 The DNA was stored at Ϫ80 C until used as a template for PCR amplification.
Amplification of a region of the herpesvirus DNApackaging protein (terminase) gene was performed with nested, degenerate primers targeted to highly conserved regions of the gene. 18 First-round amplification was performed with the degenerate forward primer A2 (5Ј-TTGTGGACGAGRSNMAYTTYAT-3Ј) and reverse primer B1 (5Ј-ACAGCCACGCCNGTNCCNG-ANGC-3Ј), each at a final concentration of 0.6 M with 1.0 unit HotStarTaq a in the manufacturer's buffer containing 1.5 mM MgCl 2 and 0.2 mM (each) deoxynucleoside triphosphate (dNTP) in a final reaction volume of 25 l. Thermocycling conditions for the first-round amplification were 95 C (12 minutes), followed by 10 cycles of denaturation (95 C, 30 seconds), annealing (68 C, 20 seconds), and extension (72 C, 90 seconds) with the annealing temperature in these cycles reduced by 2 C each cycle. An additional 40 cycles of denaturation (95 C, 30 seconds), annealing (46 C, 20 seconds), and extension (72 C, 90 seconds) were performed followed by a final extension at 72 C for 7 minutes. Second-round amplification of 1 l of the first-round reaction product was performed with the degenerate forward primer A3 (5Ј-GCAAGAT-CATNTTYRTNTCNTC-3Ј) and reverse primer B2 (5Ј-TGTTGGTCGTRWANGCNGGRTC-3Ј) using the same amplification protocol as described for the firstround reaction. A single amplification product of approximately 425 bp was observed after the secondround reaction. For each step in DNA amplification, strict protocols were followed to prevent cross-contamination of samples. Amplification products (10 l) were observed in a 2% agarose, 1ϫ TAE gel by ethidium bromide staining and ultraviolet transillumination. 37 Gel images were recorded with a Kodak DC120 Zoom digital camera and the Kodak Digital Science Electrophoresis Documentation and Analysis System 120. b Specific amplification of a fragment of the DNA-packaging protein gene from equine gammaherpesviruses was performed with the forward primer EHV␥F (5Ј-AACTCCTCSGACCAGACCA-3Ј) and the reverse primer EHV␥R (5Ј-SACCACCTTGTGCATGTTG-3Ј), each at a final concentration of 0.6 M with 1.0 unit HotStarTaq b in the manufacturer's buffer containing 1.5 mM MgCl 2 and 0.2 mM (each) dNTPs in a final reaction volume of 25 l. Thermocycling conditions for the firstround amplification were 95 C (12 minutes), followed by 10 cycles of denaturation (95 C, 30 seconds), annealing (67 C, 20 seconds), and extension (72 C, 60 seconds), with the annealing temperature in these cycles reduced by 1 C for each cycle. An additional 40 cycles of denaturation (95 C, 30 seconds), annealing (57 C, 20 seconds), and extension (72 C, 60 seconds) were performed followed by a final extension at 72 C for 7 minutes. Amplification products (10 l) were analyzed by ethidium bromide-stained agarose gel electrophoresis as described above.
After nested amplification with the degenerate primers, products of the appropriate size (approximately 425 bp) were excised from the agarose gel and purified with the Qiaex II gel extraction kit. b Purified products were either sequenced directly using the herpesvirus A3 or B2 primer or cloned using pGEM T Easy. c When amplified fragments were sequenced directly, a minimum of 3 sequencing reactions were performed for each product. When amplified fragments were cloned, a minimum of 3 clones were sequenced with either the universal forward or universal reverse sequencing primer. Nucleotide sequencing was performed by the DNA Core facility, University of Missouri-Columbia. A 379-bp product (excluding the primer sequences) was used for subsequent analyses. Nucleotide sequence analysis was performed with GeneTool version 1.0 d and BLAST 2 software.
The DNA and deduced amino acid sequences of amplified herpesvirus PCR products, excluding the primer sequences, were aligned with BLAST 2 and CLUSTAL X (version 1.8) software. Sequences for comparison were obtained from GenBank and corresponded to a portion of ORF 29b of EHV2 41 (nucleotide positions 77,082-77,466 of GenBank accession no. NC001650), which is homologous to exon 2 of HSV1 gene U L 15. 25 Phylogenetic analyses of DNA and amino acid alignments were performed using maximum parsimony methods (DNAPARS or PROTPARS) and distance matrix methods (DNADIST or PROTDIST followed by NEIGHBOR) within the PHYLIP software package. 15 Data sets were subjected to bootstrap analysis 14 based on 100 resamplings of the original data set using the SEQBOOT program to produce a majority-rule consensus tree. Completed tree files were observed using TreeView 1.5. 29 The EHV2 viral stock (strain H-40) was obtained from the National Veterinary Services Laboratory (reagent no. 041-EDV; Ames, IA). Equine herpesvirus 2 virus titration was performed on primary equine embryonic kidney cells grown in Dulbecco minimum essential media supplemented with 10% fetal bovine serum, 0.1% gentamicin, and 1% amphotericin B and held at 37 C in a humidified 5% CO 2 incubator. To determine the titer of the virus stock, serial 10-fold dilutions were performed in growth media before inoculation of equine embryonic kidney cells. Tissue culture infectious dose fifty percent end point titers (TCID 50 ml Ϫ1 ) were calculated. 31 Three independent titration assays were performed, and the results were averaged to determine the final titer of the viral stock.
The herpesvirus DNA-packaging gene sequence fragments obtained in this study have been deposited in the National Center for Biotechnology Information database and have been assigned GenBank accession numbers AF495531 (EHV5), AF535209 (AsHV4.1), AF535210 (AsHV4.2), AF535207 (AsHV5), and AF535208 (AsHV6).
Consensus primer PCR targeted to the herpesvirus DNA-packaging gene 18 amplified a 425-bp product from samples of EHV5, 2 substrains of the recently identified AsHV4, AsHV5, and a novel putative viral pathogen herein designated AsHV6. Nucleotide sequence analysis demonstrated that novel gene fragments, which corresponded to the DNA-packaging genes of other herpesviruses and is a putative homolog of HSV1 gene U L 15, 25 had been detected. Exclusion of the primer sequences yielded a 381-bp fragment. A 3-base (single amino acid) deletion was observed in EHV5, AsHV4, AsHV5, and AsHV6 compared with EHV2 ( Fig. 1A, 1B) . Pairwise alignment of the novel sequences to the corresponding region of the EHV2 DNA-packaging gene demonstrated that the 5Ј end of the fragments was more similar among the isolates analyzed than the 3Ј end ( Fig. 1A) . A similar pattern was noted when pairwise alignments were performed for the deduced amino acid sequences (Fig. 1B) . Over the entire fragment, the novel sequences ranged from 88.0% to 88.8% identical to EHV2 (Table 1 ). In general, higher levels of identity (ranging from 88.4% to 99.4%) were observed when the novel sequences were compared with each other. Notably, AsHV5 and AsHV6 were found to be 98.4% and 95.2% identical, respectively, to EHV5 on the nucleotide level. Two substrains of AsHV4, designated AsHV4.1 and AsHV4.2, were nearly identical (99.4% on the nucleotide level) to each other but only 88.0-90.5% identical to the other equine gammaherpesviruses. For each comparison, similar patterns of identity values were found for the deduced amino acid sequences (Table 1) . Based on analysis of this and previous 21 data, there is not sufficient evidence to demonstrate that AsHV4.1 and AsHV4.2 are distinct strains of gammaherpesvirus; yet, the sequence differences in highly conserved domains of the genome indicate that they are not identical to each other.
Phylogenetic analysis was performed on the basis of alignments with known, representative alpha-, beta-, and gammaherpesvirus DNA-packaging gene-deduced amino acid sequences (Fig. 2) . The trees produced using both parsimony and distance methods were essentially identical. The known herpesvirus DNA-packaging gene sequences clustered into the predicted her-pesvirus subfamilies, as has been demonstrated by others using similar phylogenetic methodologies. [11] [12] [13] 24, 36, 42 Notably, all known gammaherpesviruses of equids formed a separate clade within the Gammaherpesvirinae subfamily.
Using the novel sequence reported in this study, a specific PCR assay was developed to detect gammaherpesviruses of equids. Oligonucleotide primers selected from conserved regions of the DNA-packaging gene (Fig. 1A) generated an amplification product of 279 bp. A quantified EHV2 viral stock demonstrated that both the degenerate nested assay 18 and the specific (nonnested) assay were capable of routinely detecting approximately 1 TCID 50 (Fig. 3A) . Amplification of cloned, quantified EHV2 DNA template found that the specific (nonnested) reaction was routinely capable of detecting 0.04 fg of template (Fig. 3) , which corre- Phylogenetic tree for the DNA-packaging gene proteins of representative alpha-, beta-, and gammaherpesviruses plus the newly described sequence of the equine gammaherpesviruses EHV5 as well as AsHV4.1, AsHV5, and AsHV6. Alignments were performed using CLUSTAL X (version 1.8); subsequently, the unrooted tree was generated using the distance matrix program NEIGHBOR with the jumble option evoked. Distance values were calculated using the PROTDIST program with the Dayhoff percent accepted mutation matrix. Bootstrap values greater than 50 are shown, and the branch lengths represent relative genetic distances. The herpesviruses used for comparison and their accession numbers are as follows: AHV1 (alcelaphine herpesvirus 1, NC002531); AtHV3 (ateline herpesvirus 3, NP001987); BHV1 (bovine herpesvirus 1, Z48053); BHV4 (bovine herpesvirus 4, AF139096); CaHV3 (callitrichine herpesvirus 3, AF091062); CPHV2 (caprine herpesvirus 2, AF327834); CeHV15 (cercopithecine herpesvirus 15, AF091054); DHV (deer herpesvirus, AY055731); EETV (elephant endotheliotropic herpesvirus, AAD24548); EBV (Epstein-Barr virus, HHV4; P03219); EHV1 (equine herpesvirus 1, NP041054); EHV2 (equine herpesvirus 2, NC001650); EHV4 (equine herpesvirus 4, NP045262); FHV1 (feline herpesvirus 1, AF079124); GHV1 (gallid herpesvirus 1, AJ131832); GHV2 (gallid herpesvirus 2, AF147806); HCMV (human cytomegalovirus, HHV5; P16732); HHV6 (human herpesvirus 6, P24443); HHV7 (human herpesvirus 7, NP043815); HHV8 (Kaposi's sarcoma virus, U93872); HSV1 (herpes simplex virus 1, P04295); HVS (saimiriine herpesvirus 2, Q01020); HV68 (murine gammaherpesvirus 68, U97553); LHV2 (leporid herpesvirus 2, AF091069); MMRV (macaca mulatta rhadinovirus 17577, AF083501); OHV2 (ovine herpesvirus 2, AF327835); VZV (varicella-zoster virus, HHV3; P09294).
sponded to approximately 10 genomic copies. Amplification products of the predicted size were also generated from the DNA template purified from EHV5, AsHV4.1, AsHV4.2, AsHV5, and AsHV6 (data not shown). To assess the specificity of this assay, amplification was performed using DNA template purified from a range of alpha-and gammaherpesviruses (Fig.  3B) . No specific products were detected after amplification of 0.5-50 ng DNA template from characterized stocks of equine herpesvirus 1, equine herpesvirus 3, equine herpesvirus 4, bovine herpesvirus 1, feline herpesvirus 1, bovine lymphotropic herpesvirus, bo-vine herpesvirus 4, herpesvirus of white-tailed deer, or ovine herpesvirus 2 (OHV2). In addition, amplification of DNA extracted from lung, kidney, and spleen of a known uninfected horse did not produce a specific product.
The Gammaherpesvirinae subfamily is composed of a large number of viruses, including several newly described viruses. 7, 11, 13, 22, 23, 36 A number of gammaherpesviruses are thought to be primary pathogens, causing a variety of diseases. For example, alcelaphine herpesvirus 1 (AHV1) and OHV2 are the etiologic agents of malignant catarrhal fever (MCF), a severe and fre- quently fatal disease of a broad range of ruminant species. Recently, a novel gammaherpesvirus was detected in white-tailed deer with lesions very similar to MCF caused by AHV1. 22 This putative pathogen has been shown to be genomically similar to both AHV1 and OHV2. It is interesting to note that both AHV1 and OHV2 are not pathogenic in their natural (reservoir) hosts, wildebeest and sheep, respectively, suggesting that the herpesvirus associated with MCF in white-tailed deer may also have an unknown reservoir host. In humans, the gammaherpesvirus Epstein-Barr virus (EBV) is the etiologic agent of infectious mononucleosis. In addition, evidence has suggested that EBV may also be the cause of Burkitt's lymphoma. 33 In addition to the well-recognized pathogens within the Gammaherpesvirinae, the etiologic role of several viruses within this subfamily is largely unknown, although still under investigation. For example, a pathogenic role for bovine herpesvirus 4 has long been questioned. However, recent work has suggested that this virus may be a cause of endometritis in postparturient cattle. 17 A second gammaherpesvirus of cattle, bovine lymphotropic herpesvirus, has been implicated as a cofactor in bovine leukemia virus pathogenesis. 36 Recently, AsHV4, AsHV5, and AsHV6 were detected in DNA extracted from lung samples of adult donkeys having characteristic interstitial pneumonia with syncytial cell formation, as described previously. 21 In a majority of these cases, the respiratory disease was fatal, and the herd of origin frequently had a history of fatal respiratory disease of adult donkeys. Although an etiologic role for these closely related putative gammaherpesviruses has not been proven, a complete gross and microscopic necropsy examination coupled with diagnostic testing (e.g., virological, bacteriological, and toxicological testing) failed to identify any other plausible cause of the observed disease for numerous cases investigated during several years. Importantly, it should be noted that testing of unaffected donkeys, many of which were from the same herds, has failed to identify the presence of these putative viral pathogens in animals without respiratory disease. 21 To date, virus isolation of AsHV4, AsHV5, or AsHV6 has not been successful despite repeated inoculation attempts on a variety of primary and continuous cell lines; thus, experimental inoculations to further define the role of these putative pathogens have not been possible.
Because the importance of equine gammaherpesviruses as pathogens has not been proven, a specific PCR assay for rapid and sensitive detection was developed using the novel sequences reported in this study. This assay was designed to detect all known gammaherpesviruses of equids without the need for a nested, degenerate amplification strategy. After optimization, the analytical sensitivity of a single round of amplification with the specific primers was demonstrated to be approximately equivalent to that of the DNA-packaging gene-nested consensus primer PCR assay. 18 The oligonucleotide primers used in the PCR assay described in this study were selected from conserved domains within the DNA-packaging protein gene based on the alignment of all available sequences from equid gammaherpesviruses ( Fig. 1) . Although sequences were not available for the putative gammaherpesvirus detected in zebras and a Somali wild ass, 13 these viruses were shown to be closely related to AsHV4 and AsHV5 based on the alignments of the DNA polymerase gene sequence 21 and thus could reasonably be expected to be amplified by the specific DNA-packaging gene PCR assay. Unfortunately, nucleotide sequence data have not been reported for AsHV2, 6 the first gammaherpesvirus detected in donkeys; thus, the phylogenetic relationship of this virus to other gammaherpesviruses of equids cannot be assessed at this time. Previous reports have described PCR assays for the specific amplification of either EHV2 or EHV5. 10, 16, 27, 32 However, these assays were all designed to specifically amplify either EHV2 or EHV5 (but not both) and thus would likely not amplify DNA from AsHV4, AsHV5, or AsHV6.
In summary, a novel sequence has been determined for the DNA-packaging protein gene, which is a putative homolog of the HSV1 gene U L 15, 25 of a group of related gammaherpesviruses of equids. The newly described partial sequence of a DNA-packaging protein gene of EHV5, AsHV4, AsHV5, and AsHV6 provides evidence that AsHV4, AsHV5, and AsHV6 are members of the Gammaherpesvirinae subfamily. Consistent with sequence analysis of a portion of the DNA polymerase gene, 21 AsHV4 and AsHV5 are most similar to EHV5 and EHV2. Phylogenetic analysis supports the presence of a separate clade for these viruses of equids within the Gammaherpesvirinae subfamily. A specific PCR assay was designed for this group of putative pathogens, and it is envisioned that this assay will allow further definition of the role of equine gammaherpesviruses in disease by allowing rapid and sensitive detection, screening of suspected clinical cases, and identification of samples for virus isolation procedures.
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